ID
19577
Beschrijving
A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00320541
Link
https://clinicaltrials.gov/show/NCT00320541
Trefwoorden
Versies (1)
- 11-01-17 11-01-17 -
Geüploaded op
11 januari 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00320541
Eligibility Breast Cancer NCT00320541
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00320541
- StudyEvent: Eligibility
C0027627 (UMLS CUI [2,1])
C0006141 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3,1])
C0178784 (UMLS CUI [3,2])
C0449381 (UMLS CUI [1,2])
C0205476 (UMLS CUI [1,3])
C2986665 (UMLS CUI [1,2])
C0443288 (UMLS CUI [1,2])
C2987220 (UMLS CUI [2,1])
C0884358 (UMLS CUI [2,2])
C0085732 (UMLS CUI [2,3])
C0849535 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1299582 (UMLS CUI [1,2])